Generation of a documented technique for genetic studies of small discrete populations of normal and malignant B cells

Kim Steve Bergkvist(Chr. Hansen (Denmark)), Hans Erik Johnsen(Herlev Hospital), Mette Nyegaard(Statens Serum Institut), Alexander Schmitz(Chr. Hansen (Denmark)), Jannie Lassen Pedersen, Julie Støve Bødker(Chr. Hansen (Denmark)), Martin Bøgsted(Chr. Hansen (Denmark)), Martin Nørgaard(Copenhagen University Hospital), Michael Gaihede(Chr. Hansen (Denmark)), Marie-Louise M. Grønholdt, John Bæch(Aalborg University Hospital), Karen Dybkær(Aalborg University Hospital), Frank Svendsen Jensen, Martin Perez
Unknown
January 1, 2012
Cited by 0

Related Papers

Common variants conferring risk of schizophrenia
|Nature|2009|1.7k
Mapping neurotransmitter systems to the structural and functional organization of the human neocortex
|Nature Neuroscience|2022|773
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma
|Blood|2009|390